المؤلفون: S.S. Islam, Kwonjune J. Seung, Mir Zeeshan Ali Khan, J Kliesckova, Y M Tassew, Nara Melikyan, Carole D. Mitnick, Naira Khachatryan, D Damtew, Francis Varaine, Helena Huerga, Anita Mesic, P Lenggogeni, H Karakozian, N Lachenal, M Mofolo, Saman Ahmed, Stephen Wanjala, S. Cloez, Cathy Hewison, Leonid Lecca, Aamir J. Khan, Christophe Perrin, Uzma Khan, M Richard, Palwasha Khan, K Herboczek, Mathieu Bastard, Stalz Charles Vilbrun, Alex Telnov, S Maretbayeva, Tinatin Kotrikadze, Molly F. Franke, Michael Rich

المصدر: The International Journal of Tuberculosis and Lung Disease. 24:1081-1086

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, business.industry, Antitubercular Agents, MEDLINE, Public relations, Scientific evidence, Drug market, Pharmacovigilance, 03 medical and health sciences, 0302 clinical medicine, Infectious Diseases, Country level, Pharmaceutical Preparations, 030228 respiratory system, Humans, Medicine, 030212 general & internal medicine, Market barriers, business, Human resources, Pace

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72f7b136d4c251286bc9fdd23e541d83
https://doi.org/10.5588/ijtld.20.0141